Bridger Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Bridger Management’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-474,800	Closed	-$11.4M	–	48
2014 Q2	$11.4M	Sell	474,800 -1,025,200	-68%	-$10.7M	0.81%	31
2014 Q1	$9.04M	Sell	1,500,000 -750,000	-33%	-$5.23M	0.6%	37
2013 Q4	$13.5M	Sell	2,250,000 -2,110,628	-48%	-$9.77M	0.94%	33
2013 Q3	$22.6M	Buy	4,360,628 +1,100,000	+34%	+$4.82M	1.62%	29
2013 Q2	$11.8M	Buy	+3,260,628	New	+$13.3M	0.87%	31

Bridger Management's IDIX Position: Q3 2014 in Review

Bridger Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 474,800 shares — an estimated $11.4M sold.

Bridger Management first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $22.6M in Q3 2013. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Bridger Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Bridger Management sold 474,800 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $11.4M.
Bridger Management first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
Bridger Management's IDENIX PHARMACEUTICALS INC position peaked at $22.6M in Q3 2013.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Bridger Management's 13F filing for Q3 2014, filed 14 Nov 2014.